has been cited by the following article(s):
|
[1]
|
Guidelines for the diagnosis and treatment of depressive disorders by integrating Chinese and Western medicine (English edition)
General Psychiatry,
2025
DOI:10.1136/gpsych-2024-101747
|
|
|
|
|
[2]
|
WHO scalp acupuncture (WSA) in the treatment of depression and anxiety: three case reports (part II)
Chinesische Medizin / Chinese Medicine,
2025
DOI:10.1007/s00052-025-00153-y
|
|
|
|
|
[3]
|
Proprietary Medicines Containing Bupleurum chinense DC. (Chaihu) for Depression: Network Meta-Analysis and Network Pharmacology Prediction
Frontiers in Pharmacology,
2022
DOI:10.3389/fphar.2022.773537
|
|
|
|
|
[4]
|
Research progress on classical traditional chinese medicine formula xiaoyaosan in the treatment of depression
Frontiers in Pharmacology,
2022
DOI:10.3389/fphar.2022.925514
|
|
|
|
|
[5]
|
Antidepressant effects of the traditional Chinese herbal formula Xiao-Yao-San and its bioactive ingredients
Phytomedicine,
2022
DOI:10.1016/j.phymed.2022.154558
|
|
|
|
|
[6]
|
Study of efficacy and safety of Jiaotai pill in the treatment of depression
Medicine,
2020
DOI:10.1097/MD.0000000000019999
|
|
|
|